Concepedia
Statistics
Publications
22
Citations
600
H-Index
15
Active since
1985
Affiliations
University of Lisbon(Current)
The Open University
San Francisco General Hospital
University of California, San Francisco
National Institute for Biological Standards and Control
Maria de Jesus Perry is an author at University of Lisbon specializing in pharmacology, drug discovery, and medicinal chemistry.
Publications per year
1985–2023
The inhibition of antigen‐induced eosinophilia and bronchoconstriction by CDP840, a novel stereo‐selective inhibitor of phosphodiesterase type 4
B. Hughes, D. Howat, H. Lisle et al. · British Journal of Pharmacology · 1996 · 95 citations · Full text
Medicine, Immunology, Pharmacology +15
CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors
Rakki P. Alexander, Graham J. Warrellow, Michael A. W. Eaton et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 57 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +9
Enantiopure Indolizinoindolones with in vitro Activity against Blood‐ and Liver‐Stage Malaria Parasites
Nuno A. L. Pereira, Ângelo Monteiro, Marta Machado et al. · ChemMedChem · 2015 · 50 citations
Pharmacy, Medicinal Chemistry, Pharmacology +13
Unreliability of Current Serum Fibrin Degradation Product (FDP) Assays
Patrick J. Gaffney, Maria de Jesus Perry · Thrombosis and Haemostasis · 1985 · 43 citations
Pharmacy, Immunology, Clinical Biochemistry +12
Synthesis, Anticancer Activity and UPLC Analysis of the Stability of Some New Benzimidazole-4,7-dione Derivatives
Katarzyna Błaszczak-Świątkiewicz, Maria de Jesus Perry, Elżbieta Mikiciuk‐Olasik · Molecules · 2013 · 42 citations · Full text
Medicine, Bioengineering, Ophthalmology +15
1–5 of 22